GENE ONLINE|News &
Opinion
Blog

FDA
Pfizer’s Talzenna approved for breast cancer treatment
2018-10-25
M&A
Targeted cancer radiopharma specialist – ENDOCYTE INC.’s acquisition
2018-10-23
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Tracking “OFF THE SHELF” CAR-T Cell therapy & an IPO worth $100M
2018-10-15
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
Cancer immunotherapy researchers earn prestigious Nobel for 2018
2018-10-02
Clash of three migraines medications & cost benefit for patients
2018-10-01
Watching Biosimilar Entrants Alongside Blockbuster Patent Expiry Countdown
2018-09-25
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
US FDA Allows Phase II Clinical Trials for China’s anti-HIV Two-Drug Combo Therapy
2018-09-07
FDA Released Draft Guidance for Pregnant Women in Clinical Trials
2018-04-19
1 22 23 24
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top